Home / Products / Cancer (Tumor) Cell Lines / OCI-AML-2
OCI-AML-2
Datasheet Protocol

OCI-AML-2

Cat. No. ARC0682
Product Type:

Cancer (Tumor) Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Blood (peripheral blood)

Growth Properties:

Suspension

In stock
$1,300.00 / Vial
Ask a Question

Short Description 🔒

OCI-AML-2 is a cancer cell line of acute myeloid leukemia (AML), isolated from in situ; peripheral blood.
 
Synonym: OCI/AML-2; OCIAML-2; OCI-AML2; OCI/AML2; OCI AML2; OCIAML2; AML-2; Ontario Cancer Institute-Acute Myeloid Leukemia-2

Recommended Products

PALLD Knockout SK-HEP-1 Polyclonal Cells PALLD Knockout SK-HEP-1 Polyclonal Cells Cat. No. ARG15798 MYLK3 Knockout HEK293T Polyclonal Cells MYLK3 Knockout HEK293T Polyclonal Cells Cat. No. ARG4056 GCH1 Knockout T47D Polyclonal Cells GCH1 Knockout T47D Polyclonal Cells Cat. No. ARG12006 GSE1 Knockout SK-HEP-1 Polyclonal Cells GSE1 Knockout SK-HEP-1 Polyclonal Cells Cat. No. ARG32514 AFF4 Knockout HEK293T Polyclonal Cells AFF4 Knockout HEK293T Polyclonal Cells Cat. No. ARG37892 Ly96 Knockout RAW 264.7 Cell Line Ly96 Knockout RAW 264.7 Cell Line Cat. No. ARG0708
Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Product Type:
Cancer (Tumor) Cell Lines
Species:
Homo sapiens (Human)
Tissue Source:
Blood (peripheral blood)
Disease:
Acute myeloid leukemia (AML)
Growth Mode:
Suspension
Age:
65 years
Sex of Donor:
Male
Derived From Site:
In situ; Peripheral blood
Size/Quantity:
1 million
Shipping info:
Cryopreserved in vials and shipped on dry ice

Cell Engineering Information

No cell engineering information available.

Immortalization Information

No immortalization information available.

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Mycoplasma testing:
Negative for mycoplasma through PCR analysis
Sterility testing:
Daily monitoring confirms that the cells are free from bacterial, yeast, and fungal contamination.
Pathogens:
Cells tested negative for HIV-1, HBV, and HCV.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description 🔒

Complete description is available upon request.

Related Products You May Also Like

CDKN1A Knockout CAL27 Polyclonal Cells

CDKN1A Knockout CAL27 Polyclonal Cells

Cat. No. ARG11587
 NTPCR Knockout Hela Polyclonal Cells

NTPCR Knockout Hela Polyclonal Cells

Cat. No. ARG8567
 AURKA Knockout THP-1 Polyclonal Cells

AURKA Knockout THP-1 Polyclonal Cells

Cat. No. ARG23459
 IPP Knockout HAP1 Polyclonal Cells

IPP Knockout HAP1 Polyclonal Cells

Cat. No. ARG34592
 CCDC102A Knockout 786-O Polyclonal Cells

CCDC102A Knockout 786-O Polyclonal Cells

Cat. No. ARG42871
 MIA3 Knockout HEK293T Polyclonal Cells

MIA3 Knockout HEK293T Polyclonal Cells

Cat. No. ARG3876